Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy

por Boyero, Laura, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Noguera-Uclés, José Francisco, Molina-Pinelo, Sonia, Bernabé-Caro, Reyes
Publicado 2020

Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain

por Isla, Dolores, Lopez-Brea, Marta, Espinosa, María, Arrabal, Natalia, Pérez-Parente, Diego, Carcedo, David, Bernabé-Caro, Reyes
Publicado 2023

Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab

por Sánchez-Gastaldo, Amparo, Muñoz-Fuentes, Miguel A., Molina-Pinelo, Sonia, Alonso-García, Miriam, Boyero, Laura, Bernabé-Caro, Reyes
Publicado 2021

Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

por Alonso-García, Miriam, Sánchez-Gastaldo, Amparo, Muñoz-Fuentes, Miguel A., Molina-Pinelo, Sonia, Boyero, Laura, Benedetti, Johana Cristina, Bernabé-Caro, Reyes
Publicado 2022

Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer

por Boyero, Laura, Noguera-Uclés, José Francisco, Castillo-Peña, Alejandro, Salinas, Ana, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Benedetti, Johana Cristina, Bernabé-Caro, Reyes, Paz-Ares, Luis, Molina-Pinelo, Sonia
Publicado 2023

The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Can...

por Noguera-Uclés, José Francisco, Boyero, Laura, Salinas, Ana, Cordero Varela, Juan Antonio, Benedetti, Johana Cristina, Bernabé-Caro, Reyes, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Paz-Ares, Luis, Molina-Pinelo, Sonia
Publicado 2020

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer

por Nadal, Ernest, Oré-Arce, Martín, Remon, Jordi, Bernabé-Caro, Reyes, Covela-Rúa, Marta, de Castro-Carpeño, Javier, Massutí-Sureda, Bartomeu, Guillot-Morales, Mónica, Majem, Margarita, Maestu-Maiques, Inmaculada, Morilla-Ruíz, Idoia, Gironés, Regina
Publicado 2023

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

por Majem, Margarita, Cobo, Manuel, Isla, Dolores, Marquez-Medina, Diego, Rodriguez-Abreu, Delvys, Casal-Rubio, Joaquín, Moran-Bueno, Teresa, Bernabé-Caro, Reyes, Pérez-Parente, Diego, Ruiz-Gracia, Pedro, Arroyo, Marta Marina, Paz-Ares, Luis
Publicado 2021

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program

por Bernabé-Caro, Reyes, Garrido, Pilar, García-Campelo, Rosario, Palmero, Ramón, Artal, Ángel, Bayona, Cristina, Rodríguez-Abreu, Delvys, López-Brea, Marta, Paredes, Alfredo, Vicente, David, Sánchez Torres, José Miguel, Majem, Margarita, Diz, Pilar, Gordo, Rocío, Coca, Margarita, de Castro, Javier
Publicado 2022

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227

por Brahmer, Julie R., Lee, Jong-Seok, Ciuleanu, Tudor-Eliade, Bernabe Caro, Reyes, Nishio, Makoto, Urban, Laszlo, Audigier-Valette, Clarisse, Lupinacci, Lorena, Sangha, Randeep, Pluzanski, Adam, Burgers, Jacobus, Mahave, Mauricio, Ahmed, Samreen, Schoenfeld, Adam J., Paz-Ares, Luis G., Reck, Martin, Borghaei, Hossein, O'Byrne, Kenneth J., Gupta, Ravi G., Bushong, Judith, Li, Li, Blum, Steven I., Eccles, Laura J., Ramalingam, Suresh S.
Publicado 2023

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

por Sierra-Rodero, Belén, Cruz-Bermúdez, Alberto, Nadal, Ernest, Garitaonaindía, Yago, Insa, Amelia, Mosquera, Joaquín, Casal-Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Laza-Briviesca, Raquel, Casarrubios, Marta, García-Grande, Aránzazu, Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

por Laza‐Briviesca, Raquel, Cruz‐Bermúdez, Alberto, Nadal, Ernest, Insa, Amelia, García‐Campelo, María del Rosario, Huidobro, Gerardo, Dómine, Manuel, Majem, Margarita, Rodríguez‐Abreu, Delvys, Martínez‐Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Casarrubios, Marta, Sierra‐Rodero, Belén, Tarín, Carlos, García‐Grande, Aránzazu, Haymaker, Cara, Wistuba, Ignacio I., Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

por Provencio, Mariano, Serna-Blasco, Roberto, Nadal, Ernest, Insa, Amelia, García-Campelo, M. Rosario, Casal Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Pereira, Eva, Royuela, Ana, Calvo, Virginia, Martín-López, Javier, García-García, Francisco, Casarrubios, Marta, Franco, Fernando, Sánchez-Herrero, Estela, Massuti, Bartomeu, Cruz-Bermúdez, Alberto, Romero, Atocha
Publicado 2022

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

por Casarrubios, Marta, Cruz-Bermúdez, Alberto, Nadal, Ernest, Insa, Amelia, García Campelo, María del Rosario, Lázaro, Martín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, de Castro-Carpeño, Javier, Cobo, Manuel, López-Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Barquín, Miguel, Laza-Briviesca, Raquel, Sierra-Rodero, Belén, Parra, Edwin R., Sanchez-Espiridion, Beatriz, Rocha, Pedro, Kadara, Humam, Wistuba, Ignacio I., Romero, Atocha, Calvo, Virginia, Provencio, Mariano
Publicado 2021